SCHEMBL1865152

SCHEMBL1865152

C[C@@]1(n2ccc(N)nc2=O)O[C@H](CO)[C@@H](O)[C@@]1(N)O.N[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3A Q14432 3/20 0.46
SLC29A1 Q99808 2/20 0.46
PDE4D Q08499 1/20 0.46
LMNA P02545 3/20 0.40
THRB P10828 1/20 0.40
MTOR P42345 1/20 0.40
MDM2 Q00987 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
P2RY2 P41231 5/20 0.39
SLC28A1 O00337 1/20 0.39
SLC28A2 O43868 1/20 0.39
SLC28A3 Q9HAS3 1/20 0.39
P2RY4 P51582 3/20 0.38
P2RY6 Q15077 1/20 0.35
P2RY12 Q9H244 2/20 0.35
CACNA1F O60840 2/20 0.33
ALB P02768 2/20 0.33
MAPT P10636 2/20 0.33
CACNA1D Q01668 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1880455 0.83 PDE3A (0.46) PDE3ASLC29A1PDE4DLMNATHRB
SCHEMBL1865151 0.83 PDE3A (0.58) PDE3ASLC29A1PDE4DLMNATHRB
SCHEMBL1846921 0.80 SLC29A1 (0.51) PDE3ASLC29A1PDE4DLMNATHRB
SCHEMBL547062 0.80 SLC29A1 (0.57) PDE3ASLC29A1PDE4DP2RY2SLC28A1
SCHEMBL28006945 0.78 SLC28A1 (0.43) SLC29A1P2RY2SLC28A1SLC28A2SLC28A3
SCHEMBL547055 0.77 PDE3A (0.74) PDE3ASLC29A1PDE4DLMNATHRB
Phosphoric Acid SCHEMBL4575970 0.76 SLC28A1 (0.53) SLC29A1P2RY2SLC28A1SLC28A2SLC28A3
Phosphoric Acid SCHEMBL20769288 0.76 SLC28A1 (0.53) SLC29A1P2RY2SLC28A1SLC28A2SLC28A3
SCHEMBL7027795 0.76 SLC29A1 (0.53) PDE3ASLC29A1PDE4DP2RY2SLC28A1
SCHEMBL17184312 0.76 PDE3A (0.67) PDE3ASLC29A1PDE4DLMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010057160-A9 RELEASABLE FUSOGENIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS ENZON PHARMACEUTICALS, INC. (US) 2011-05-05 WO disclosed